Lumiracoxib
Lumiracoxib is a potent, selective and orally active COX-2 inhibitor with a Ki value of 0.06 μM[1]. Lumiracoxib acts as a nonselective NSAID with anti-inflammatory, analgesic and antipyretic activities. Lumiracoxib can be used for osteoarthritis and bone cancer research[1][2].
Product Specifications
CAS Number
220991-20-8
Product Name Alternative
COX-189
UNSPSC
12352005
Hazard Statement
H302
Target
COX
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Cancer; Metabolic Disease; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/lumiracoxib.html
Purity
99.93
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(O)CC1=CC(C)=CC=C1NC2=C(F)C=CC=C2Cl
Molecular Formula
C15H13ClFNO2
Molecular Weight
293.72
Precautions
H302
References & Citations
[1]Ronald Esser, et al. Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2. Br J Pharmacol. 2005 Feb;144 (4) :538-50.|[2]Alyson Fox, et al. Anti-hyperalgesic activity of the cox-2 inhibitor lumiracoxib in a model of bone cancer pain in the rat. Pain
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
COX-1; COX-2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
14295151 3x 1.0 µg DNA
C20orf20 CRISPR All-in-one AAV vector set (with saCas9)(Human)
Sign In for Pricing
View Details 
NBP2-72891F 0.1 mL
Mouse Monoclonal N-Cadherin Antibody (OTI2G7) [FITC]
Sign In for Pricing
View Details